Blog

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

November, 2024

Blog

Our results reveal a physiologic function of Mdm2 in BM-MSC, identify a previously unknown role of p53 pathway in BM-MSC–mediated support in AML

Photo from faculty.mdanderson.org

Jun 26, 2023, 18:40

Our results reveal a physiologic function of Mdm2 in BM-MSC, identify a previously unknown role of p53 pathway in BM-MSC–mediated support in AML

In a post by Jared K. Burks on Linkedin, it says, “This is a double celebration as not only did I get to contribute to this wonderful article, but the first author, Russell Pourebrahim was just promoted to Assistant Professor. Congrats Rasoul on both the article and the promotion, very happy for you.
Mesenchymal stromal cells (MSCs) are a key component of the bone marrow (BM) niche, providing essential support required for the maintenance of hematopoietic stem cells. To advance our understanding of physiological functions of p53 and Mdm2 in BM-MSCs, we developed traceable conditional mouse models targeting Mdm2 and/or Trp53 in vivo. Our results reveal a physiologic function of Mdm2 in BM-MSC, identify a previously unknown role of p53 pathway in BM-MSC–mediated support in AML and expand our understanding of the mechanism of hematopoietic toxicity of MDM2is.”

For Article : Click here

Source:

bone marrow cancer cancer care hematopoietic Jared K. Burks Mesenchymal stromal cells Oncology Research Russell Pourebrahim

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Donald Trump: Thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of HHS

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Isabel Mestres: In a world where the fight against cancer knows no borders, collaboration is not optional - it’s essential

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Blog

Nov 18, 2024, 16:59

Refining the First Strike Against EGFR-Mutated Advanced NSCLC - PeerView Institute for Medical Education

Blog

Nov 18, 2024, 16:55

Ruth Fein: Together we can change the conversation around chronic cancers

Blog

Nov 18, 2024, 16:50

Cervical Cancer Elimination Day of Action 2024 - Medicaid Cancer Foundation

Blog

Nov 18, 2024, 16:50

Michael Duruisseaux: Prognostic value of neutrophil to lymphocyte ratio before adjuvant durvalumab in locally advanced NSCLC

Blog

Nov 18, 2024, 16:39

Cristiane Bergerot: Psycology Society suffering in patients with cancer remains a worldwide unmet need

Insight

Nov 18, 2024, 16:36

Very last chance to apply for the CancerX Accelerator Startup

Insight

Nov 18, 2024, 16:31

Andreas Koulouris: Incredible opportunity to participate in the Lung Cancer Preceptorship in Paris

Insight

Nov 18, 2024, 16:04

Manlio Vinciguerra: Circulating histone signature of Diffuse Intrinsic Pontine Glioma

Insight

Nov 18, 2024, 15:58

Petros Grivas: Fantastic experience to present at WA medical oncology society

Opinion

Nov 18, 2024, 15:57

Marking 4 years of WHO's Cervical Cancer Elimination movement - IARC

Insight

Nov 18, 2024, 15:52

The 15th ENGOT Gynaecological Cancer Academy workshop

Blog

Nov 18, 2024, 15:33

Sami Mansfield: Cancer doesn’t wait. Neither should we